Skip to content

Survival Analysis after Hepatectomy for Hepatocellular Carcinoma: A Retrospective Cohort Study

Survival Analysis after Hepatectomy for Hepatocellular Carcinoma: A Retrospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200006003
Enrollment
Unknown
Registered
2022-05-13
Start date
2022-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

1:Hepatectomy

Sponsors

Zhongshan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? It meets the diagnostic criteria of HCC and the characteristics of TCM syndrome differentiation and treatment; ? The general health status (PS) score is 0-2; ? Child Pugh is classified as a or B; ? The clinical stages of liver cancer in China (CNLC) are stage IA, stage IB, stage IIA and stage IIB; ? Radical treatment (Hepatectomy) after diagnosis of HCC is treatment measures and entered between December 2014 and may 2015; ? Postoperative TCM treatment mainly takes traditional Chinese medicine decoction (or granule); ? Postoperative medical treatment mainly included general medical treatment, transcatheter hepatic arterial chemoembolization (TACE) and systematic treatment; ? The original case data are relatively complete.

Exclusion criteria

Exclusion criteria: ? Those who do not have the conditions for radical treatment; ? Patients with serious adverse reactions after traditional Chinese medicine and traditional Chinese medicine treatment; ? Patients with invasion or extrahepatic metastasis; ? Severe basic liver disease or combined with other serious basic diseases (including other malignant tumors); ? Serious lack of original case data.

Design outcomes

Primary

MeasureTime frame
DFS;OS;

Countries

China

Contacts

Public ContactWeimin She

Zhongshan Hospital Affiliated to Fudan University

she.weimin@zs-hospital.sh.cn13761634489

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026